Triggers for attacks in familial mediterranean fever: Application of the case-crossover design

American Journal of Epidemiology

Volumn 175, Issue 10, 2012, Pages 1054-1061

  Yenokyan, Gayane ^a   Armenian, Haroutune K ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b NONE

Author keywords

Armenia; familial Mediterranean fever; life change events; precipitating factors

Indexed keywords

DISEASE CONTROL; DISEASE TREATMENT; FOOD CONSUMPTION; LIFESTYLE; PHYSIOLOGY; REGRESSION ANALYSIS;

ARMENIA; ARTICLE; CONTROLLED STUDY; FAMILIAL MEDITERRANEAN FEVER; FEMALE; FOLLOW UP; HUMAN; LIFE STRESS; LIPID DIET; MAJOR CLINICAL STUDY; MALE; MENSTRUATION; PHYSICAL ACTIVITY;

ADOLESCENT; ADULT; COLCHICINE; CROSS-OVER STUDIES; DIETARY FATS; EXERCISE; FAMILIAL MEDITERRANEAN FEVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIFE CHANGE EVENTS; LOGISTIC MODELS; MALE; MENSTRUATION; MULTIVARIATE ANALYSIS; PERIODICITY; PRECIPITATING FACTORS; QUESTIONNAIRES; RECURRENCE; STRESS, PHYSIOLOGICAL; STRESS, PSYCHOLOGICAL; TUBULIN MODULATORS; YOUNG ADULT;

ARMENIA; YEREVAN;

EID: 84861362801     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwr460     Document Type: Article

References (32)

1. Aksentijievich I, Centola M, Deng ZM, et al. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium. Cell. 1997;90(4):797-807.
2. Armenian HK, Sha'ar KH. Epidemiologic observations in familial paroxysmal polyserositis. Epidemiol Rev. 1986;8: 106-116.
3. Deger SM, Ozturk MA, Demirag MD, et al. Health-related quality of life and its associations with mood condition in familial Mediterranean fever patients. Rheumatol Int. 2011; 31(5):623-628.
4. Armenian HK. Genetic and environmental factors in the aetiology of familial paroxysmal polyserositis. An analysis of 150 cases from Lebanon. Trop Geogr Med. 1982;34(2): 183-187. (Pubitemid 12065325)
5. Cazeneuve C, Ajrapetyan H, Papin S, et al. Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever. Am J Hum Genet. 2000;67(5): 1136-1143.
6. La ReginaM, Nucera G, DiacoM, et al. Familial Mediterranean fever is no longer a rare disease in Italy. Eur J Hum Genet. 2003;11(1):50-56.
7. Shohat M, Livneh A, Zemer D, et al. Twin studies in familial Mediterranean fever. Am J Med Genet. 1992;44(2): 179-182.
8. Gershoni-Baruch R, Shinawi M, Shamaly H, et al. Familial Mediterranean fever: the segregation of four different mutations in 13 individuals from one inbred family: genotype-phenotype correlation and intrafamilial variability. Am J Med Genet. 2002;109(3):198-201. (Pubitemid 34438663)
9. Mimouni A,Magal N, Stoffman N, et al. FamilialMediterranean fever: effects of genotype and ethnicity on inflammatory attacks and amyloidosis. Pediatrics. 2000;105(5):E70. (doi:10.1542/peds.105.5.e70).
10. Kastner DL. Intermittent and periodic arthritis syndromes. In: Koopman WJ, ed. Arthritis and Allied Conditions: A Textbook of Rheumatology. Vol 1. Philadelphia, PA: Lippincott Williams & Wilkins; 2001:1411-1461.
11. Schwabe AD, Peters RS. Familial Mediterranean fever in Armenians. Analysis of 100 cases. Medicine (Baltimore). 1974;53(6):453-462.
12. Sohar E, Gafni J, Pras M, et al. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med. 1967;43(2):227-253.
13. Ben-Chetrit E, Levy M. Colchicine: 1998 update. Semin Arthritis Rheum. 1998;28(1):48-59.
14. Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol. 1991;133(2):144-153.
15. Maclure M, Mittleman MA. Should we use a case-crossover design Annu Rev Public Health. 2000;21:193-221. (doi:10.1146/annurev.publhealth.21.1.171). (Pubitemid 30480321)
16. Wright DG,Wolff SM, Fauci AS, et al. Efficacy of intermittent colchicine therapy in familial Mediterranean fever. Ann Intern Med. 1977;86(2):162-165. (Pubitemid 8042792)
17. Mö ller J, Theorell T, de Faire U, et al. Work related stressful life events and the risk of myocardial infarction. Case-control and case-crossover analyses within the Stockholm Heart Epidemiology Programme (SHEEP). J Epidemiol Community Health. 2005;59(1):23-30. (Pubitemid 40037082)
18. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24(4):385-396.
19. Mittleman MA, Maclure M, Tofler GH, et al. Triggering of acute myocardial infarction by heavy physical exertion. Protection against triggering by regular exertion. Determinants of Myocardial Infarction Onset Study Investigators. N Engl J Med. 1993;329(23):1677-1683. (Pubitemid 23346917)
20. Thompson FE, Byers T. Dietary assessment resource manual. J Nutr. 1994;124(11 suppl):2245S-2317S. (Pubitemid 24357686)
21. Greenland S. Confounding and exposure trends in casecrossover and case-time-control designs. Epidemiology. 1996; 7(3):231-239. (Pubitemid 26120367)
22. StataCorp LP. Stata statistical software, release 10. College Station, TX: Stata Corporation; 2007.
23. Sarkisian T, Ajrapetyan H, Shahsuvaryan G. Molecular study of FMF patients in Armenia. Curr Drug Targets Inflamm Allergy. 2005;4(1):113-116. (Pubitemid 40584861)
24. Cazeneuve C, Hovannesyan Z, Geneviève D, et al. Familial Mediterranean fever among patients from Karabakh and the diagnostic value of MEFV gene analysis in all classically affected populations. Arthritis Rheum. 2003;48(8):2324-2331. (Pubitemid 36959215)
25. Hayashi A, Suzuki T, Shimizu A, et al. Periodic fever suppressed by reserpine [letter]. Lancet. 1976;1(7959):592.
26. Barakat MH, El-Khawad AO, Gumaa KA, et al. Metaraminol provocative test: a specific diagnostic test for familial Mediterranean fever. Lancet. 1984;1(8378):656-657. (Pubitemid 14169483)
27. Sav T, Ozbakir O, Kelestimur F, et al. Adrenal axis functions in patients with familial Mediterranean fever. Clin Rheumatol. 2006;25(4):458-461.
28. Korkmaz C, Colak O, Alatas O, et al. Early blunted cortisol response to insulin induced hypoglycaemia in familial Mediterranian fever. Clin Exp Rheumatol. 2002;20(4 suppl. 26): S8-S12.
29. Ben-Chetrit E, Levy M. Reproductive system in familial Mediterranean fever: an overview. Ann Rheum Dis. 2003; 62(10):916-919. (Pubitemid 37159485)
30. Mellinkoff SM, Schwabe AD, Lawrence JS. A dietary treatment for familial Mediterranean fever. Arch Intern Med. 1961;108(1):80-85.
31. Khachadurian AK, Armenian HK. The management of familial paroxysmal polyserositis (familial Mediterranean fever). Experience with low-fat diets and Clofibrate. J Med Liban. 1972;25(6):495-502.
32. Onat AM, Oztürk MA, Ozcxakar L, et al. Selective serotonin reuptake inhibitors reduce the attack frequency in familial Mediterranean fever. Tohoku J Exp Med. 2007;211(1):9-14. (Pubitemid 46062215)